Deborah  Rasin net worth and biography

Deborah Rasin Biography and Net Worth

SVP of Hill-Rom
Deborah M. Rasin was appointed chief legal officer and secretary in January 2016. Before joining Hillrom, Ms. Rasin served as vice president, secretary and general counsel at DENTSPLY International Inc., the NASDAQ-listed leading manufacturer and distributor of dental and other consumable healthcare products. Prior to DENTSPLY, Ms. Rasin served as vice president of Legal, general counsel and secretary of Samsonite Corporation, and subsequently was a partner in a private law practice in London, England. Prior to joining Samsonite, Ms. Rasin spent ten years as a senior commercial and corporate attorney for General Motors Corporation. In addition to residing in the United States and the United Kingdom, she has lived and worked in Hong Kong, Switzerland and Israel. Ms. Rasin holds a bachelor’s degree from Harvard College and juris doctor from Harvard Law School.

What is Deborah Rasin's net worth?

The estimated net worth of Deborah Rasin is at least $4.75 million as of June 7th, 2021. Ms. Rasin owns 30,432 shares of Hill-Rom stock worth more than $4,746,175 as of November 23rd. This net worth evaluation does not reflect any other assets that Ms. Rasin may own. Learn More about Deborah Rasin's net worth.

How do I contact Deborah Rasin?

The corporate mailing address for Ms. Rasin and other Hill-Rom executives is 130 East Randolph Street Suite 1000, Chicago IL, 60601. Hill-Rom can also be reached via phone at (312) 819-7200 and via email at [email protected]. Learn More on Deborah Rasin's contact information.

Has Deborah Rasin been buying or selling shares of Hill-Rom?

Deborah Rasin has not been actively trading shares of Hill-Rom over the course of the past ninety days. Most recently, Deborah Rasin sold 10,223 shares of the business's stock in a transaction on Monday, June 7th. The shares were sold at an average price of $110.67, for a transaction totalling $1,131,379.41. Following the completion of the sale, the senior vice president now directly owns 30,432 shares of the company's stock, valued at $3,367,909.44. Learn More on Deborah Rasin's trading history.

Who are Hill-Rom's active insiders?

Hill-Rom's insider roster includes Andreas Frank (SVP), Paul Johnson (SVP), Mary Ladone (SVP), and Deborah Rasin (SVP). Learn More on Hill-Rom's active insiders.

Deborah Rasin Insider Trading History at Hill-Rom

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/7/2021Sell10,223$110.67$1,131,379.4130,432View SEC Filing Icon  
11/12/2019Sell4,739$103.97$492,713.8331,001View SEC Filing Icon  
8/7/2019Sell5,500$103.00$566,500.0020,939View SEC Filing Icon  
4/12/2018Sell7,590$86.02$652,891.8014,028View SEC Filing Icon  
See Full Table

Deborah Rasin Buying and Selling Activity at Hill-Rom

This chart shows Deborah Rasin's buying and selling at Hill-Rom by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hill-Rom Company Overview

Hill-Rom logo
Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.
Read More

Today's Range

Now: $155.96
Low: $155.96
High: $155.96

50 Day Range

MA: $155.74
Low: $155.05
High: $156.18

2 Week Range

Now: $155.96
Low: $93.34
High: $156.22

Volume

N/A

Average Volume

656,912 shs

Market Capitalization

$10.30 billion

P/E Ratio

41.92

Dividend Yield

0.62%

Beta

0.55